Back

A novel mouse model for psoriasis-atherosclerosis (PSO-AS) comorbidity

31 August 2025 (16:15 - 17:00)
Organised by: Logo
Congress Presentation Part of: Inflammatory and cellular mechanisms driving atherosclerosis and vascular dysfunction Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Fangshun Tan

Beijing (China)

4 More presentations in this session

Presentation thumbnail
RGS5-deficiency impedes humoral inflammatory response under surgical stress in atherosclerotic mouse model
Mr A. Anilkumar (Oldenburg, DE)
Abstract Slides Video
Presentation thumbnail
Toll-like receptor 9 promotes aortic chondrogenesis and calcification in apolipoprotein e-deficient mice
Doctor R. Bando (Tokushima, JP)
Abstract Slides Video
Presentation thumbnail
Resident LYVE-1+ macrophages contribute to endothelin-1 clearance and attenuate atherosclerosis via endothelin receptor B
Doctor S. Mause (Aachen, DE)
Abstract Slides Video
Presentation thumbnail
Single-cell profiling of myocardial epicardial adipose tissue - insights into coronary artery disease pathophysiology
Doctor S. Doppler (Munich, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Inflammatory and cellular mechanisms driving atherosclerosis and vascular dysfunction

The Event

Event poster

ESC Congress 2025

31 August 2025 16:15 CET
You may be interested in
thumbnail
Congress Presentation
HDL-associated phosphatidylserine normalizes vessel wall metabolism and architecture in atherosclerosis
thumbnail
Congress Presentation
Cardiac manifestations of psoriasis and palmoplantar pustulosis: the PSOCADIA study
thumbnail
Congress Presentation
Evidence from normal human arteries: IRF7 triggers atherosclerosis by enhancing vascular smooth muscle cells inflammation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources